Zhengji Li

Mr. Zhengji Li

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2022 in Electronics Letters
Verified
Journal Article
Open access
SLSiyu Li
Siyu Li
KZKui Zhao
Kui Zhao
JYJin Yang
Jin Yang
XJXinyun Jiang
Xinyun Jiang
ZLZhengji Li
Zhengji Li
ZMZicheng Ma
Zicheng Ma
In the field of public opinion analysis, sentiment analysis is an important basic research branch. Previous studies have successfully proved that the advanced transformer pre‐training model can be applied to this scenario in Uyghur and other low‐resource language scenarios. However, the majority of these studies are based on the traditional language anchor point and rely on the pre‐training model's cross‐lingual understanding ability. The Senti‐eXLM model proposed in this paper employs a method that allows for adaptively expanding the model's knowledge domain and dynamically adjusting the model for Uyghur language in order to improve the language's understanding and representation capability, thereby increasing the accuracy of text emotion analysis. Experiments on publicly available data sets demonstrate that when compared to the original model, the model's emotion classification accuracy is improved by 6.17%, the training convergence speed is increased by 27%, and the average reasoning time is increased by only 11%.

18 August 2023 in Applied Intelligence
Verified
Journal Article
Closed access
PDF file
ZLZhengji Li
Zhengji Li
YWYuexin Wu
Yuexin Wu
JYJin Yang
Jin Yang
JCJiangchuan Chen
Jiangchuan Chen
TLTianrui Li
Tianrui Li

24 September 2025 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
HZHuajin Zhang
Huajin Zhang
FLFujun Liu
Fujun Liu
JZJunyilang Zhao
Junyilang Zhao
YWYong Wang
Yong Wang
YSYuge Shen
Yuge Shen
HYHanshuo Yang
Hanshuo Yang
A biomimetic lymph node-like poriferous microsphere (PM) was developed to establish a 3D culture platform optimized for both T cell and CAR-T cell proliferation.